News
The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...
Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback